deferiprone has been researched along with Cataract, Membranous in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parakh, N | 1 |
| Sharma, R | 1 |
| Prakash, O | 1 |
| Mahto, D | 1 |
| Dhingra, B | 1 |
| Sharma, S | 1 |
| Chandra, J | 1 |
| Mehdizadeh, M | 1 |
| Nowroozzadeh, MH | 1 |
2 other studies available for deferiprone and Cataract, Membranous
| Article | Year |
|---|---|
Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.
Topics: beta-Thalassemia; Cataract; Cerebellar Ataxia; Child; Deferiprone; Humans; Iron Chelating Agents; Ma | 2015 |
Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.
Topics: Administration, Oral; Adult; beta-Thalassemia; Cataract; Deferiprone; Humans; Iron Chelating Agents; | 2009 |